Voices Against Brain Cancer (VABC) Reacts to Study Suggesting a Link between Allergies and a Reduced Risk of Brain Cancer

Share Article

Following a recent study suggesting a link between allergies and a reduced risk of brain cancer, the nonprofit organization Voices Against Brain Cancer releases a statement.

On September 6, 2012, nonprofit organization, Voices Against Brain Cancer, responded to a recent study suggesting a link between allergies and a reduced risk of brain cancer, a development that many scientists have long suspected but have only recently gained more ground through an “extremely organized and comprehensive” study.

According to Lindsay Abrams, “Scientists have long suspected that there's an association between allergies and gliomas, a common and often fatal type of brain tumor.” Abrams goes on to state, “People who tested positive for allergy-related antibodies had an almost 50 percent lower risk of developing a glioma 20 years later.” The study concluded that, “[t]he link between allergies and reduced risk of glioma is measurable and possibly causal, especially for women, and can be observed at least 20 years before diagnosis.”

Clay Darrohn, representative for Voices Against Brain Cancer, responded to this study by stating, “The results of this study will hopefully provide more insight between the contributing factors that make some individuals more susceptible to brain cancer than others. It is the hope of VABC that studies such at this will provide answers and hope for those that are affected by this devastating disease.”

The full study, “Association Between Prediagnostic IgE Levels and Risk of Glioma” was published in the Journal of National Cancer Institute.

Voices Against Brain Cancer has a wide variety of initiatives in place for brain cancer research, awareness and support. Their research grants fund cutting-edge research programs that will have a monumental impact on the diagnosis and treatment of brain cancer. VABC currently funds research at several esteemed institutions such as Brookhaven National Laboratory, Cleveland Clinic, Columbia, Cornell, Duke, Harvard, John Hopkins, Memorial Sloan-Kettering and Yale, to name a few.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Scott Darrohn
Visit website